SoniVie announced that it received FDA breakthrough device designation for its Tivus renal artery denervation technology.
Tivus (therapeutic intra-vascular ultrasound system) is designed for treating resistant hypertension through renal artery denervation. The system previously received breakthrough designation for treating pulmonary arterial hypertension (PAH) in September 2019.
Get the full story at our sister site, Medical Tubing & Extrusion.